SAN FRANCISCO, July 19, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that it has entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems, in an all-cash transaction that values Augmedix at approximately $139 million in equity value. Under the terms of the agreement, Augmedix stockholders will receive $2.35 per share in cash upon completion of the pro ...

SAN FRANCISCO, June 20, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today that Emergency Services Inc., a physician-owned emergency medicine services group in Columbus, Ohio, is introducing Augmedix Go ED to physicians in the emergency department (ED) at the second-largest healthcare system in central Ohio. Augmedix Go ED is the industry's first fully automated, generative AI (GenAI) powered medical documentation product for EDs ...

SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reiterated its expectations in advance of management's participation at the William Blair Annual Growth Stock Conference. Management continues to expect second quarter 2024 revenue to increase slightly sequentially from the first quarter of 2024, and second quarter 2024 GAAP gross margins to increase from the first quarter of 2024 by 50 to 100 basis points. For the ...

SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reiterated its expectations in advance of management’s participation at the William Blair Annual Growth Stock Conference. Management continues to expect second quarter 2024 revenue to increase slightly sequentially from the first quarter of 2024, and second quarter 2024 GAAP gross margins to increase from the first quarter of 2024 by 50 to 100 basis points. For the ...

Augmedix (NASDAQ:AUGX) stock is sliding lower on Tuesday after the medical documentation solutions company released its Q1 2024 earnings report.The bad news for AUGX investors comes from its outlook update. This has the company expecting its 2024 revenue to range from $52 to $55 million. This would see it missing Wall Street’s revenue estimate of $61.15 million for the year.Augmedix CEO Manny Krakaris explains the reason for this low revenue outlook below.“We have observed a slow-down in purchasing commitme ...

Investor Presentation Nasdaq: AUGX May 2024 ...

财务数据和关键指标变化 - 公司第一季度收入为1350万美元,同比增长40% [36] - 毛利率为47.1%,同比提升150个基点,主要得益于规模效应和向海外转移美国服务人员 [37] - 经营亏损为640万美元,同比增加130万美元,主要由于2023年11月融资后的人员扩张 [38][39] - 调整后EBITDA亏损为510万美元,同比增加80万美元 [40] - 经营活动现金流出为820万美元,同比增加200万美元 [41] 各条业务线数据和关键指标变化 - 公司正在积极推进Augmedix Go和Augmedix Go Assist两款AI产品,这些产品毛利率较高但ARPU较低 [26][27] - 公司正在与HCA Healthcare合作,优化和部署Augmedix Go产品,预计将为公司带来重大收入增长 [18][19] - 公司正在与多家大型医疗机构开展Augmedix Go的试点项目,反响良好 [20] 各个市场数据和关键指标变化 - 公司正在积极拓展新客户,但部分现有客户在评估AI产品的同时放缓了对Augmedix Live的扩展 [23][24] - 部分大型客户正在从Augmedix Live转向较低价格的Augmedix Go Assist产品,反映了Go Assist产品的吸引力 [24] 公司战略和发展方向及行业竞争 - 公司正在加快从技术服务型公司向SaaS和AI优先型公司的转型,这将为股东带来更高价值 [27] - 公司提供了行业内最全面的文档产品组合,可以满足不同场景和需求,这是公司的核心竞争优势 [28][29][30][31] - 公司拥有11年的行业经验和大量的临床数据积累,这为公司的AI产品开发提供了重要支撑 [33] 管理层对经营环境和未来前景的评论 - 医疗行业正在以前所未有的速度采用新的生成式AI技术,这为公司的产品提供了良好的市场机遇 [49][50] - 但一些纯AI解决方案在实际应用中存在局限性,这为公司的混合解决方案带来了发展机会 [32][49] - 公司调整了2024年全年收入指引,主要由于现有客户转向较低价格的AI产品以及新客户采购放缓 [23][24][43][44] - 公司仍有信心通过持续投入和产品创新,在未来市场竞争中脱颖而出 [27][28][33] 问答环节重要的提问和回答 问题1 **Ryan Daniels 提问** 客户从Augmedix Live转向Augmedix Go Assist的过程和时间节点是什么 [54][58][59][61] **Paul Ginocchio 回答** 大部分合同中有90天的过渡期,公司会尽量优化客户的长期ROI,而不是短期收入 [59][61] 问题2 **Elizabeth Anderson 提问** 公司在Augmedix Go产品的销售情况如何,客户评估和采购的进度如何 [67][68][69][70] **Manny Krakaris 回答** 目前市场上有42家公司提供生成式AI医疗文档解决方案,客户正在进行大量试点评估,在完成评估之前不会有大规模采购 [68][69][70] 问题3 **Aaron Wukmir 提问** Augmedix Go Assist产品的客户反馈和采购情况如何 [80][81][82] **Manny Krakaris 回答** 公司已经收到一些大客户的强烈需求,对产品前景感到很有信心,因为这反映了客户对纯AI产品期望过高的失望 [80][81] **Paul Ginocchio 回答** Augmedix Go和Go Assist产品可以让公司深入到更广泛的医生群体,从而带来更好的长期收入增长 [82]

Table of Contents Delaware 83-3299164 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 111 Sutter Street, Suite 1300, San Francisco, California 94104 (Address of principal executive offices) (Zip Code) Title of each class Trading Symbol (s) Name on each exchange on which registered Common Stock, $0.0001 par value per share AUGX The Nasdaq Stock Market LLC Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☑ Smaller reporting company ☑ Emerg ...

SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024. RBC Capital Markets Global Healthcare Conference (New York): Management will participate in a fireside chat on May 15 at 10:30 a.m. ET, and be available for 1x1 investor meetings. The webcast link for the fireside chat can be found at https://ir. ...

SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market closes on Monday, May 13, 2024. Following the release, management will host a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)Live webcast: https://viavid.webcasts.com/starthere.jsp?ei=1666696&tp_key=f217 ...